Back to results

Massachusetts Institute of Technology

Impact of Drug Supply Chain Security Act on US pharmaceutical industry under decentralized information flow

Abstract

dc:description.abstract

Drug counterfeiting is one of the major issues in the pharmaceutical industry across the world. These products could cause damages from ineffective treatments to death of patients. In order to fight against counterfeit drugs, the US government introduced Drug Supply Chain Security Act (DSCSA) mandating that all prescription drugs should be serialized. In addition, it mandates all pharmaceutical companies in the U.S. to provide tracking documents in response to a tracing request from FDA. While the act aims to improve drug security across the pharmaceutical industry, it poses a huge impact across the supply chain on both physical flow and information flow. This research evaluates the supply chain impact at an industry level. In this thesis, we evaluate the supply chain impact of Matryoshka model and Unit level model supported by a decentralized information flow. The thesis then evaluates the supply chain impact from three aspects, operational cost, IT infrastructure cost and capital investment. We reference Nabiyeva and Wu's research on centralized information flow model to conduct an exhaustive supply chain impact evaluation across the centralized model and the decentralized model. We conclude that among all these scenarios, unit level model under centralized information flow design bears the highest cost as it requires higher IT investment. On the other hand, the matryoshka model under decentralized information flow has a least supply chain impact from the cost perspective with low IT investment.

Degree

thesis:*
Department dc:contributor.department
Massachusetts Institute of Technology. Supply Chain Management Program.
Grantor dc:publisher
Massachusetts Institute of Technology
Year dc:date.issued
2017

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Chang, Meng Ying, M. Eng. Massachusetts Institute of Technology./
  • Mohan, Raghavendran
Advisor dc:contributor.advisor
  • Bruce C. Arntzen.

Subjects

dc:subject × 1

Rights

dc:rights
Statement dc:rights
  • MIT theses are protected by copyright. They may be viewed, downloaded, or printed from this source but further reproduction or distribution in any format is prohibited without written permission.
Language dc:language.iso
eng

Identifiers

dc:identifier.*
Handle dc:identifier.uri
http://hdl.handle.net/1721.1/112875
OAI identifier oai:identifier
oai:dspace.mit.edu:1721.1/112875

Chain of custody

source
Harvested from
MIT
Base URL
dspace.mit.edu/oai/request
Last updated
2026-07-22
Source record
OAI-PMH GetRecord
citation

Chang, Meng Ying, M. Eng. Massachusetts Institute of Technology./; Mohan, Raghavendran. Impact of Drug Supply Chain Security Act on US pharmaceutical industry under decentralized information flow. Massachusetts Institute of Technology, 2017. http://hdl.handle.net/1721.1/112875